RE: RNS - new premises15 Aug 2019 15:00
I agree that this is good news but timing is everything.
The 4th of June RNS stated 'Tranche Two, to be drawn between February and April 2020, contingent upon $5.0 million net equity proceeds and subject to agreed revenue targets for the from dCELL and BioRinse product sales'.
Today's RNS states 'Phase one will commence immediately with part of the new building being converted into office, distribution and warehouse space, allowing for additional clean rooms to be built in the original facility, which are expected to be operational by the end of H1 2020'
That seems to be a lot of investment. When does the cash call come? When will the Woodford dilema be overcome?